CONMED Corporation Sees FY24 Adj. EPS $3.95-$4.02 vs Prior Range Of $4.25-$4.35, Revenue $1.305B-$1.315B vs Prior Range Of $1.33B-$1.355B
Portfolio Pulse from Benzinga Newsdesk
CONMED Corporation has revised its FY24 adjusted EPS guidance to $3.95-$4.02, down from the previous range of $4.25-$4.35. Additionally, the company has lowered its revenue forecast to $1.305 billion-$1.315 billion from the prior range of $1.33 billion-$1.355 billion.
July 31, 2024 | 9:27 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
CONMED Corporation has lowered its FY24 adjusted EPS and revenue guidance, indicating potential challenges ahead. The revised EPS range is $3.95-$4.02, down from $4.25-$4.35, and the revenue forecast is now $1.305 billion-$1.315 billion, down from $1.33 billion-$1.355 billion.
The downward revision in both EPS and revenue guidance suggests that CONMED Corporation may be facing operational or market challenges. This is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100